Drug intelligence / Profile preview

Retinduo

Development stage
Unknown
Lead developer
Cantabria Labs
Modality
Small Molecules
Administration
Topical
01

Overview

Retinduo is a cosmeceutical retinoid technology developed by Cantabria Labs for topical application in the treatment of skin aging and dermatologic cosmetic use. The technology combines pure retinol encapsulated in microsponges and retinal (retinaldehyde) delivered in nanovesicles, along with a booster of naturally-derived ingredients that enhances efficacy. These active ingredients function as small molecule retinoids that target skin cell retinoid receptors (RAR/RXR) to promote epidermal renewal, retexturization, and collagen synthesis. Marketed under the brand name ENDOCARE Renewal Retinoid Intensive Serum, Retinduo is designed to reduce signs of aging such as wrinkles, fine lines, and uneven skin texture while maintaining high tolerability and minimizing the irritation typically associated with potent retinoid treatments.

Brand names
ENDOCARE Renewal Retinoid Intensive Serum
Other names
RetinDuo
02

Targets

RARG (Retinoic acid receptor gamma)PTGFR (Prostaglandin F2 alpha receptor)

Beyond the preview

Go deeper on Retinduo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinduo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call